Skip to main content
. 2013 Nov;51(11):3877–3879. doi: 10.1128/JCM.01730-13

Table 2.

Antimicrobial susceptibilities and MICs of KPC-2-producing Klebsiella pneumoniae isolates in South Korea

Antimicrobial agent MIC (mg/liter) and susceptibilitya
1st isolate (Kpn-DK2) 2nd isolate (KPN 1010) National surveillance
This study
5 isolates 1 isolate KPN MP14 KPN MP35 KPN MP52
Ampicillin >64 (R) >256 (R) ≥32 (R) ≥32 (R) ≥32 (R)
Amoxicillin-clavulanate >256 (R) ≥32 (R) ≥32 (R) ≥32 (R)
Piperacillin >256 (R) ≥128 (R) ≥128 (R) ≥128 (R)
Piperacillin-tazobactam >256 (R) ≥128 (R) ≥128 (R) ≥128 (R)
Cephalothin ≥64 (R) ≥64 (R) ≥64 (R) ≥64 (R)
Cefoxitin >256 (R) ≥64 (R) ≥64 (R) ≥64 (R)
Cefotetan >256 (R)
Cefotaxime >128 (R) >256 (R) 128->256 (R) >256 (R) 8 (R) 8 (R) 8 (R)
Ceftazidime >64 (R) ≥64 (R) 64->256 (R) 128 (R) 16 (R) ≥64 ≥64 (R)
Aztreonam >64 (R) >256 (R) 256->256 (R) 256 (R) ≥64 (R) ≥64 ≥64 (R)
Cefepime >64 (R) >256 (R) 4 (S) 8 (S) 8 (S)
Imipenem 32 (R) >256 (R) 32–128 (R) 64 (R) 2 (I) 2 (I) 4 (R)
Meropenem 16 (R) >256 (R) 64–256 (R) 32 (R) 2 (I) 2 (I) ≥16 (R)
Ertapenem >32 (R) >32 (R) >32 (R) >32 (R)
Amikacin 48 (R) 64->256 (R) >256 (R) ≥64 (R) ≥64 (R) ≥64 (R)
Tobramycin ≥16 (R) ≥16 (R) ≥16 (R) ≥16 (R)
Gentamicin >64 (R) 4 (S) 2–4 (S) >256 (R) 4 (S) 4 (S) 4 (S)
Levofloxacin ≥8 (R) ≥8 (R) ≥8 (R) ≥8 (R)
Ciprofloxacin >32 (R) >32 (R) 256->256 (R) 256 (R)
Trimethoprim-sulfamethoxazole ≥320 (R) ≥320 (R) ≥320 (R) ≥320 (R)
Tigecycline 4 1 0.75–1.5 1.5 2 2 2
Colistin >64 0.25 0.25–1 1 0.25 0.25 0.25
Polymyxin B >64 0.75
a

Antimicrobial susceptibility of the first isolate was tested by a broth microdilution method, that of the second isolate was tested by Vitek 2 or Etest, the six national surveillance strains were tested by Etest or agar dilution, and the isolates in this study were tested by Vitek 2 or Etest. S, susceptible; I, intermediate; R, resistant.